aibioMDNA Medicenna Therapeutics Corp.
Medicenna Therapeutics (MDNA) news
Medicenna Therapeutics Corp. is a public biotech or pharmaceutical company listed on TSX under the ticker MDNA, recorded under Canada. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Medicenna Therapeutics news
We have not published a story on Medicenna Therapeutics yet. When there is news, it will appear here.
Medicenna Therapeutics annual financials
| Line | FY ended Mar 31, 2023 | FY ended Mar 31, 2022 |
|---|---|---|
| Research and development | C$9.3 million | C$14.7 million |
| Net income (loss) | -C$10.0 million | -C$22.6 million |
| Cash from operations | -C$23.6 million | |
| Cash and equivalents | C$33.6 million | C$20.5 million |
Questions about Medicenna Therapeutics
What is the ticker symbol of Medicenna Therapeutics?
Medicenna Therapeutics Corp. trades under the ticker MDNA on TSX.
Where is Medicenna Therapeutics listed?
Medicenna Therapeutics Corp. is listed on TSX. Our directory also records these other listings: NEO:MDNA; OTC:MDNAF.
What is the SEC CIK of Medicenna Therapeutics?
The SEC Central Index Key (CIK) for Medicenna Therapeutics Corp. is 1807983. Its filings are on SEC EDGAR.
How many shares does Medicenna Therapeutics have outstanding?
69,637,469 shares as of 2023-03-31, per the cover page of its 20-F filed 2023-06-27.
Which country or territory is Medicenna Therapeutics listed under?
Our directory records Medicenna Therapeutics Corp. under Canada.
What does Medicenna Therapeutics do?
Our directory classifies Medicenna Therapeutics Corp. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Medicenna Therapeutics?
The ISIN recorded for Medicenna Therapeutics Corp. is CA58490H1073.
Does aibio.space cover Medicenna Therapeutics?
aibio.space lists Medicenna Therapeutics Corp. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Medicenna Therapeutics incorporated?
SEC records list its state or country of incorporation as Z4.
Is Medicenna Therapeutics a smaller reporting company?
SEC records list Medicenna Therapeutics Corp.'s filer category as: Non-accelerated filer<br>Emerging growth company.
Where is Medicenna Therapeutics headquartered?
SEC records list its business address as 2 BLOOR STREET W., TORONTO.
When does Medicenna Therapeutics's fiscal year end?
Medicenna Therapeutics Corp.'s fiscal year ends on March 31, per SEC records.
What did Medicenna Therapeutics last file with the SEC?
Its most recent filing in our record is a 6-K filed 2024-05-13. All of its filings are on SEC EDGAR. Source.
What industry is Medicenna Therapeutics in?
Its SEC industry code (SIC 2834) is Pharmaceutical Preparations.
Which companies are similar to Medicenna Therapeutics?
Companies in our directory listed in the same country and business area as Medicenna Therapeutics: Microbix Biosystems, Onco-Innovations, Rapid Dose Therapeutics, ProMIS Neurosciences, Eupraxia Pharmaceuticals, NanoSphere Health Sciences.
Investor discussion: Medicenna Therapeutics
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
SEC filings and registration
- SEC name
- Medicenna Therapeutics Corp.
- CIK
- 1807983
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- MDNAF (OTC)
- State or country of incorporation
- Z4
- Fiscal year ends
- March 31
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Business address
- 2 BLOOR STREET W., TORONTO
- Phone
- 403-613-1453
- Shares outstanding
- 69,637,469 as of 2023-03-31 (20-F filed 2023-06-27)
Recent filings
Listing details
- Company
- Medicenna Therapeutics Corp.
- Ticker
- MDNA
- Listing
- TSX
- Country or territory
- Canada
- Business scope
- Biotechnology
- ISIN
- CA58490H1073
- Other listed symbols
- NEO:MDNA; OTC:MDNAF
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction